146 related articles for article (PubMed ID: 15787326)
21. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction.
Jiang YH; Kuo HC
PLoS One; 2017; 12(4):e0174593. PubMed ID: 28376105
[TBL] [Abstract][Full Text] [Related]
22. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
Kuo HC
Urology; 2007 Jan; 69(1):57-61; discussion 61-2. PubMed ID: 17270614
[TBL] [Abstract][Full Text] [Related]
23. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies.
Gammie A; Kaper M; Dorrepaal C; Kos T; Abrams P
Eur Urol; 2016 Feb; 69(2):361-9. PubMed ID: 26318706
[TBL] [Abstract][Full Text] [Related]
24. Recovery of Voiding Efficiency and Bladder Function in Male Patients With Non-neurogenic Detrusor Underactivity After Transurethral Bladder Outlet Surgery.
Lee KH; Kuo HC
Urology; 2019 Jan; 123():235-241. PubMed ID: 30308261
[TBL] [Abstract][Full Text] [Related]
25. Distigmine Bromide Produces Sustained Potentiation of Guinea-Pig Urinary Bladder Motility by Inhibiting Cholinesterase Activity.
Obara K; Chino D; Tanaka Y
Biol Pharm Bull; 2017; 40(6):807-814. PubMed ID: 28566624
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic drugs for treatment of recurrent urinary retention in high surgical risk/elderly BPH patients. A pilot study.
Skolarikos A; Tyritzis S; Stamatiou K
Minerva Urol Nefrol; 2012 Sep; 64(3):209-16. PubMed ID: 22971686
[TBL] [Abstract][Full Text] [Related]
27. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings.
Nitti VW; Kim Y; Combs AJ
J Urol; 1997 Feb; 157(2):600-3. PubMed ID: 8996367
[TBL] [Abstract][Full Text] [Related]
28. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity.
Kuo HC
Urology; 2003 Mar; 61(3):550-4. PubMed ID: 12639645
[TBL] [Abstract][Full Text] [Related]
29. Effect of dominant hemispheric stroke on detrusor function in patients with lower urinary tract symptoms.
Kim TG; Yoo KH; Jeon SH; Lee HL; Chang SG
Int J Urol; 2010 Jul; 17(7):656-60. PubMed ID: 20482661
[TBL] [Abstract][Full Text] [Related]
30. Effects of Distigmine on Electrical Field Stimulation-Induced Contraction of Mouse Urinary Bladder Smooth Muscles.
Obara K; Kobayashi Y; Chino D; Tanaka Y
Pharmacology; 2017; 99(3-4):106-113. PubMed ID: 27798943
[TBL] [Abstract][Full Text] [Related]
31. EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
Sekido N; Otsuki T; Kida J; Mashimo H; Wakamatsu D; Okada H; Matsuya H
Low Urin Tract Symptoms; 2020 Sep; 12(3):285-291. PubMed ID: 32410343
[TBL] [Abstract][Full Text] [Related]
32. Proposal for a urodynamic redefinition of detrusor underactivity.
Cucchi A; Quaglini S; Rovereto B
J Urol; 2009 Jan; 181(1):225-9. PubMed ID: 19013594
[TBL] [Abstract][Full Text] [Related]
33. [Cholinergic crisis following administration of distigmine bromide: a case report].
Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
[TBL] [Abstract][Full Text] [Related]
34. Sustainable Effects of Distigmine Bromide on Urinary Bladder Contractile Function.
Obara K; Tanaka Y
Pharmacology; 2020; 105(3-4):135-144. PubMed ID: 31614352
[TBL] [Abstract][Full Text] [Related]
35. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis.
Osman NI; Chapple CR; Abrams P; Dmochowski R; Haab F; Nitti V; Koelbl H; van Kerrebroeck P; Wein AJ
Eur Urol; 2014 Feb; 65(2):389-98. PubMed ID: 24184024
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
Kuo HC
J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
[TBL] [Abstract][Full Text] [Related]
37. Pressure-flow variables in patients treated with tolterodine for detrusor overactivity.
Wagg A; Malone-Lee J
BJU Int; 2003 Dec; 92(9):969-71. PubMed ID: 14632857
[TBL] [Abstract][Full Text] [Related]
38. A further report on the effect of distigmine bromide (Ubretid) on the neurogenic bladder.
Yeo J; Southwell P; Rutowski S; Marchant-Williams H
Med J Aust; 1974 Aug; 2(6):201-3. PubMed ID: 4424051
[No Abstract] [Full Text] [Related]
39. Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling.
Lemack GE; Krauss S; Litman H; FitzGerald MP; Chai T; Nager C; Sirls L; Zyczynski H; Baker J; Lloyd K; Steers WD;
J Urol; 2008 Nov; 180(5):2076-80. PubMed ID: 18804239
[TBL] [Abstract][Full Text] [Related]
40. Clinical and video urodynamic characteristics of adult women with dysfunctional voiding.
Chen YC; Kuo HC
J Formos Med Assoc; 2014 Mar; 113(3):161-5. PubMed ID: 24630033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
